secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001323885-24-000004
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure appoints former J&J executive Shlomi Nachman to Board of Directors
---------------------------------------------------------------------------

- Shlomi Nachman elected to AtriCure Board effective January 4, 2024.
- Nachman brings >25 years med device experience; was J&J Company Group Chairman for Cardiovascular and Specialty Solutions.
- He is an independent director per NASDAQ standards.
- He currently serves on boards of several private med device companies and the Beckman Foundation.
- CEO Michael Carrel says Nachman's experience in Afib market will be invaluable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388524000004/0001323885-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388524000004/atrc-20240104.htm
  HTML page:      https://secwatch.observer/filing/0001323885-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer